These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23845694)

  • 1. Distinct deleterious effects of cyclosporine and tacrolimus and combined tacrolimus-sirolimus on endothelial cells: protective effect of defibrotide.
    Carmona A; Díaz-Ricart M; Palomo M; Molina P; Pino M; Rovira M; Escolar G; Carreras E
    Biol Blood Marrow Transplant; 2013 Oct; 19(10):1439-45. PubMed ID: 23845694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defibrotide prevents the activation of macrovascular and microvascular endothelia caused by soluble factors released to blood by autologous hematopoietic stem cell transplantation.
    Palomo M; Diaz-Ricart M; Rovira M; Escolar G; Carreras E
    Biol Blood Marrow Transplant; 2011 Apr; 17(4):497-506. PubMed ID: 21126597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
    Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
    Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine A and Tacrolimus Induce Functional Impairment and Inflammatory Reactions in Endothelial Progenitor Cells.
    Meyer N; Brodowski L; von Kaisenberg C; Schröder-Heurich B; von Versen-Höynck F
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacodynamic effects of sirolimus and sirolimus-calcineurin inhibitor combinations on macrophage scavenger and nuclear hormone receptors.
    Mathis AS; Jin S; Friedman GS; Peng F; Carl SM; Knipp GT
    J Pharm Sci; 2007 Jan; 96(1):209-22. PubMed ID: 17016853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of conversion from ciclosporin to tacrolimus on endothelial progenitor cells in stable long-term kidney transplant recipients.
    Riegersperger M; Plischke M; Steiner S; Seidinger D; Sengoelge G; Winkelmayer WC; Sunder-Plassmann G
    Transplantation; 2013 Jun; 95(11):1338-45. PubMed ID: 23594858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation.
    Helmschrott M; Rivinius R; Ruhparwar A; Schmack B; Erbel C; Gleissner CA; Akhavanpoor M; Frankenstein L; Ehlermann P; Bruckner T; Katus HA; Doesch AO
    Drug Des Devel Ther; 2015; 9():1217-24. PubMed ID: 25759566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The side-effects of ciclosporine-A and tacrolimus.
    Mihatsch MJ; Kyo M; Morozumi K; Yamaguchi Y; Nickeleit V; Ryffel B
    Clin Nephrol; 1998 Jun; 49(6):356-63. PubMed ID: 9696431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gingival overgrowth in cyclosporine, tacrolimus, or sirolimus-based immunosuppressive regimens and the single nucleotide IL-6 (-174 G/C) gene polymorphism.
    Cota LO; Viana MB; Moreira PR; Gomez RS; Cortelli JR; Cortelli SC; Costa FO
    Arch Oral Biol; 2010 Jul; 55(7):494-501. PubMed ID: 20430366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnesium-deficiency does not alter calcineurin inhibitors activity in mice.
    Hulin A; Lamrani L; Sabbagh F; Tallet A; Lecerf F; Bac P; German-Fattal M
    Transpl Immunol; 2012 Jan; 26(1):55-61. PubMed ID: 21964379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of immunosuppressive drugs on spontaneous DNA repair in human peripheral blood mononuclear cells.
    Ori Y; Herman-Edelstein M; Zingerman B; Rozen-Zvi B; Gafter U; Malachi T; Gafter-Gvili A
    Biomed Pharmacother; 2012 Sep; 66(6):409-13. PubMed ID: 22795807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus and everolimus intestinal absorption and interaction with calcineurin inhibitors: a differential effect between cyclosporine and tacrolimus.
    Lamoureux F; Picard N; Boussera B; Sauvage FL; Marquet P
    Fundam Clin Pharmacol; 2012 Aug; 26(4):463-72. PubMed ID: 21631587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine A, but not tacrolimus, shows relevant inhibition of organic anion-transporting protein 1B1-mediated transport of atorvastatin.
    Amundsen R; Christensen H; Zabihyan B; Asberg A
    Drug Metab Dispos; 2010 Sep; 38(9):1499-504. PubMed ID: 20519340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ciclosporin A, tacrolimus and sirolimus on cytokine production in neonatal immune cells.
    Puzik A; Schultz C; Iblher P; Müller-Steinhardt M; Härtel C
    Acta Paediatr; 2007 Oct; 96(10):1483-9. PubMed ID: 17880416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus-transformed B-cell lines.
    Beatty PR; Krams SM; Esquivel CO; Martinez OM
    Transplantation; 1998 May; 65(9):1248-55. PubMed ID: 9603175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcineurin inhibitor-induced headache: clinical characteristics and possible mechanisms.
    Ferrari U; Empl M; Kim KS; Sostak P; Förderreuther S; Straube A
    Headache; 2005 Mar; 45(3):211-4. PubMed ID: 15836594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of tacrolimus versus cyclosporine microemulsion in primary cardiac transplant recipients: 6-month results in Taiwan.
    Wang CH; Ko WJ; Chou NK; Wang SS
    Transplant Proc; 2004 Oct; 36(8):2384-5. PubMed ID: 15561256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft-versus-host disease prophylaxis.
    Garming Legert K; Ringdén O; Remberger M; Törlén J; Mattsson J; Dahllöf G
    Oral Dis; 2021 Jul; 27(5):1217-1225. PubMed ID: 33012083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.